Spinelli F, Conti F, Caporali R, Iannone F, Cacciapaglia F, Steering Committee of the Italian Society of Rheumatology on behalf of the. Janus kinase inhibitors: between prescription authorization and reimbursability. Reumatismo [Internet]. 2023 Dec. 19 [cited 2024 Nov. 25];75(4). Available from: https://www.reumatismo.org/reuma/article/view/1627